BR112021001403A2 - usos de composições de curcuminoide - Google Patents

usos de composições de curcuminoide Download PDF

Info

Publication number
BR112021001403A2
BR112021001403A2 BR112021001403-9A BR112021001403A BR112021001403A2 BR 112021001403 A2 BR112021001403 A2 BR 112021001403A2 BR 112021001403 A BR112021001403 A BR 112021001403A BR 112021001403 A2 BR112021001403 A2 BR 112021001403A2
Authority
BR
Brazil
Prior art keywords
curcuminoids
composition
curcumin
food
turmeric
Prior art date
Application number
BR112021001403-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Pascale Elizabeth Renée FANÇA-BERTHON
Leila Denise FALCAO
Mathieu TENON
Maryline Vinal
Simona Birtic
Original Assignee
Naturex Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1812776.1A external-priority patent/GB201812776D0/en
Priority claimed from GBGB1902266.4A external-priority patent/GB201902266D0/en
Application filed by Naturex Sa filed Critical Naturex Sa
Publication of BR112021001403A2 publication Critical patent/BR112021001403A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR112021001403-9A 2018-08-06 2019-08-05 usos de composições de curcuminoide BR112021001403A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1812776.1A GB201812776D0 (en) 2018-08-06 2018-08-06 New methods and uses
GB1812776.1 2018-08-06
GBGB1902266.4A GB201902266D0 (en) 2019-02-19 2019-02-19 New methods and uses
GB1902266.4 2019-02-19
PCT/EP2019/071055 WO2020030612A1 (en) 2018-08-06 2019-08-05 Uses of curcuminoid compositions

Publications (1)

Publication Number Publication Date
BR112021001403A2 true BR112021001403A2 (pt) 2021-04-27

Family

ID=67770463

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021001403-9A BR112021001403A2 (pt) 2018-08-06 2019-08-05 usos de composições de curcuminoide

Country Status (9)

Country Link
US (3) US12059394B2 (https=)
EP (1) EP3833337A1 (https=)
JP (2) JP2021534105A (https=)
CN (1) CN112566630A (https=)
AU (1) AU2019320488B2 (https=)
BR (1) BR112021001403A2 (https=)
CA (2) CA3108123A1 (https=)
MX (1) MX2021000776A (https=)
WO (1) WO2020030612A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113208109B (zh) * 2021-04-30 2023-08-29 河南中大恒源生物科技股份有限公司 一种高生物利用度水溶姜黄素及其制备方法以及应用
CN113383881B (zh) * 2021-04-30 2023-08-29 河南中大恒源生物科技股份有限公司 一种液体水溶姜黄素及其制备方法以及应用
CN115028886B (zh) * 2022-06-21 2023-11-21 贺州学院 一种用于检测铅离子的双去甲氧基姜黄素显色薄膜、其制备方法和铅离子快速检测方法
WO2024041724A1 (en) * 2022-08-22 2024-02-29 Givaudan Sa Composition comprising curcuminoids, modified starch and/or acacia gum and saponins for use as a medicament

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786775B1 (fr) * 1998-12-04 2001-02-16 Roquette Freres Maltodextrines branchees et leur procede de preparation
JP5448511B2 (ja) * 2008-03-31 2014-03-19 三栄源エフ・エフ・アイ株式会社 ウコン色素組成物及びその調製方法
JP2011130696A (ja) * 2009-12-24 2011-07-07 Nihon Cornstarch Corp マルトデキストリンの製造方法
EP2359702B1 (en) * 2010-01-22 2014-06-04 Symrise AG Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides
WO2012105546A1 (ja) * 2011-01-31 2012-08-09 株式会社シクロケムバイオ 脂溶性物質を含む水溶液の製造方法
DE102011056111B4 (de) * 2011-12-06 2013-08-14 Sensient Colors Europe Gmbh Emulsion
ES2646214T3 (es) 2012-10-16 2017-12-12 DÖHLER GmbH Emulsión
US10674757B2 (en) * 2013-06-21 2020-06-09 Firmenich Sa Preparation of dried particles comprising menthol
US20160151440A1 (en) 2013-08-19 2016-06-02 Aurea Biolabs Private Limited A Novel Composition of Curcumin with Enhanced Bioavailability
US10016363B2 (en) 2014-09-18 2018-07-10 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
JP7128739B2 (ja) * 2016-04-01 2022-08-31 三栄源エフ・エフ・アイ株式会社 固体色素の安定化方法
JP6794190B2 (ja) * 2016-09-01 2020-12-02 株式会社ファンケル キマーゼ阻害用組成物
US20190200660A1 (en) * 2016-09-26 2019-07-04 San-Ei Gen F.F.I., Inc. Curcumin composition
WO2018083677A1 (en) * 2016-11-07 2018-05-11 Akay Flavours & Aromatics Pvt. Ltd. Green approach in enhancing the bioavailability of oils, fats and other lipophilic bioactives and compositions thereof
JP6986345B2 (ja) * 2016-11-18 2021-12-22 ロート製薬株式会社 経口組成物及びその製造方法

Also Published As

Publication number Publication date
MX2021000776A (es) 2021-06-15
JP2021534105A (ja) 2021-12-09
CN112566630A (zh) 2021-03-26
CA3108123A1 (en) 2020-02-13
JP2025003947A (ja) 2025-01-14
KR20210041037A (ko) 2021-04-14
AU2019320488B2 (en) 2025-01-23
US20250144048A1 (en) 2025-05-08
US20220280448A1 (en) 2022-09-08
EP3833337A1 (en) 2021-06-16
AU2019320488A1 (en) 2021-02-18
US20240115519A1 (en) 2024-04-11
US12220388B2 (en) 2025-02-11
US12059394B2 (en) 2024-08-13
CA3292034A1 (en) 2026-03-02
WO2020030612A1 (en) 2020-02-13

Similar Documents

Publication Publication Date Title
CN102405046B (zh) 表现出抗炎性质的药物组合物
BR112021001403A2 (pt) usos de composições de curcuminoide
Mohanty et al. Naringin as sustained delivery nanoparticles ameliorates the anti-inflammatory activity in a Freund’s complete adjuvant-induced arthritis model
JP7525473B2 (ja) クルクミノイド組成物
ES2548867T3 (es) Composición farmacéutica que presenta propiedades antiinflamatorias y antihistamínicas
US20120195871A1 (en) Stable aqueous suspension
Sampathkumar et al. Small-intestine-specific delivery of antidiabetic extracts from Withania coagulans using polysaccharide-based enteric-coated nanoparticles
Gudise et al. Antidiabetic and antihyperlipidemic effects of Argyreia pierreana and Matelea denticulata: Higher activity of the micellar nanoformulation over the crude extract
Adiki et al. Phytosomes: A novel phytoconstituent delivery approach to improve the efficacy of obesity treatment
KR102957602B1 (ko) 커큐미노이드 조성물의 용도
BR112021001405B1 (pt) Composição de curcuminoide, seu uso, processo para sua preparação, e produtos compreendendo tal composição
Dash et al. Implication of formulation strategies on the bioavailability of selected plant-derived hepatoprotectants
KR20260061431A (ko) 커큐미노이드 조성물의 용도
M Najeb et al. Renoprotective effect of taxifolin and/or vitamin c on diazinon-induced renal injury in rats
US20230263732A1 (en) Compositions comprising quillaja extract and methods of preparations and use thereof
Ting et al. Development of chrysin loaded oil-in-water nanoemulsion for improving bioaccessibility. Foods. 2021; 10: 1912
EP4588470A1 (en) Pharmaceutical composition comprising curcumin and the preparation thereof
US20220304927A1 (en) Mitochondrial Performance Enhancement Nanoemulsion Method
Gou et al. Research Progress on Nanoformulations Based on Active Components from Traditional Chinese Medicine for MASLD
US20200375920A1 (en) Compositions comprising quillaja extract and methods of preparations and use thereof
Adiki et al. For personal private use only

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B154 Notification of filing of divisional application [chapter 15.50 patent gazette]

Free format text: O PEDIDO FOI DIVIDIDO NO BR122023016571-3 PROTOCOLO 870230072981 EM 17/08/2023 14:23.